In our last article we did on Novan (NOVN), we predicted that clinical trials were approved, and now the company came out and said that they are now officially exploring COVID-19 coronavius treatment with their Nitricil technology using nitric oxide.
What is Novan (NOVN)’s Nitricil technology?
Novan’s innovative NITRICIL™ technology is the key to using nitric oxide as a medical treatment. NITRICIL™ stores the gaseous species on large polymers, which allow nitric oxide to be applied as timed-release chemical entities. This technology allows us to control the level of nitric oxide storage, the rate of release, and the molecule size for targeted delivery. The result is stabilized, druggable nitric oxide.
What is Novan (NOVN) doing right now?
Novan is now testing Nitricil technology to see if it can inhibit the replication mechanism, viral shedding and transmission in COVID-19 coronavirus or SARS-COV-2. They will be analyzing and testing via in vitro.
The company will also present at the H.C. Wainwright 22nd Annual Global Investment Conference.
In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference.
This conference will also be streamed via live video webcast that will be made available for two hours after the conference and will then be achieved for 90 days.
Novan (NOVN) is exploring federal funding
In a video tweeted by the official Novan (NOVN) account it details everything you need to know about their fight against COVID-19 and how they plan on moving forward.
In the video CEO Paula Brown Stafford announced that the company is exploring federal grant dollars for further development and treatment of oral and nasal cavity that would leverage the broad efficacy of nitric oxide.
The official results which include reporting and findings from in vitro assessments are expected to be available by the end of the year (2020).
Should you invest in Novan (NOVN) stock?
Shares of Novan (NOVN) appear to be a very good investment option, the Money Midnight Indicator is expecting its price to increase considerably in the next several months. The majority of the metrics point to this investment being highly attractive.
